Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer
- PMID: 18522932
- DOI: 10.1093/annonc/mdn353
Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer
Abstract
Background: The purpose of this study was to provide practical, evidence-based guidelines for evaluating and treating common menopausal symptoms following breast cancer.
Methods: Literature review of the causes, assessment and management of menopausal symptoms in breast cancer patients.
Results: A number of nonhormonal treatments are effective in treating hot flashes. Whether pharmacological treatment is given will depend on the severity of symptoms and on patient wishes. For severe and frequent hot flashes, the best data support the use of venlafaxine, paroxetine and gabapentin in women with breast cancer. Side-effects are relatively common with all these agents. For vaginal dryness, topical estrogen treatment is the most effective but the safety of estrogens following breast cancer is not established. There are limited data on effective treatments for sexual dysfunction during menopause.
Conclusion: Menopausal symptoms after breast cancer should be evaluated and managed as warranted using a systematic approach and may benefit from multidisciplinary input.
Similar articles
-
Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.Clin Ther. 2007 Feb;29(2):230-41. doi: 10.1016/j.clinthera.2007.02.006. Clin Ther. 2007. PMID: 17472816 Review.
-
[Ovarian Ablation in Breast Cancer Patients and the Possibility of Influencing Treatment Side Effects].Klin Onkol. 2016 Fall;29 Suppl 3:S29-38. doi: 10.14735/amko20163S29. Klin Onkol. 2016. PMID: 28118722 Czech.
-
The management of menopausal symptoms in breast cancer survivors: case-based approach.Maturitas. 2012 Nov;73(3):265-8. doi: 10.1016/j.maturitas.2012.07.010. Epub 2012 Aug 9. Maturitas. 2012. PMID: 22883373 Review.
-
Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.Menopause. 2004 Jan-Feb;11(1):11-33. doi: 10.1097/01.GME.0000108177.85442.71. Menopause. 2004. PMID: 14716179
-
Hormone Therapy and Other Treatments for Symptoms of Menopause.Am Fam Physician. 2016 Dec 1;94(11):884-889. Am Fam Physician. 2016. PMID: 27929271 Review.
Cited by
-
Phytoestrogen Treatment for Menopausal Vasomotor Symptoms after Breast Cancer.Breast Care (Basel). 2023 Jun;18(3):158-163. doi: 10.1159/000529695. Epub 2023 Feb 15. Breast Care (Basel). 2023. PMID: 37529371 Free PMC article.
-
Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?Healthcare (Basel). 2022 Aug 13;10(8):1528. doi: 10.3390/healthcare10081528. Healthcare (Basel). 2022. PMID: 36011183 Free PMC article. Review.
-
Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors.Breast Cancer Res Treat. 2021 Jun;187(2):427-435. doi: 10.1007/s10549-021-06117-7. Epub 2021 Feb 11. Breast Cancer Res Treat. 2021. PMID: 33575860
-
Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial.Breast. 2020 Dec;54:216-221. doi: 10.1016/j.breast.2020.10.015. Epub 2020 Oct 31. Breast. 2020. PMID: 33160147 Free PMC article.
-
A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.Oncologist. 2020 Dec;25(12):e1846-1854. doi: 10.1634/theoncologist.2020-0417. Epub 2020 Jun 9. Oncologist. 2020. PMID: 32459035 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
